Cryo-Cell International Inc
CCEL5.040USD
+0.080+1.61%
取引時間 （ET）15分遅れの株価
40.64M時価総額
315.78直近12ヶ月PER
詳細情報 Cryo-Cell International Inc 企業名
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
企業情報
企業コードCCEL
会社名Cryo-Cell International Inc
上場日Apr 04, 1994
最高経営責任者「CEO」Mr. Mark L. Portnoy
従業員数82
証券種類Ordinary Share
決算期末Apr 04
本社所在地700 Brooker Creek Blvd
都市OLDSMAR
証券取引所NYSE American Consolidated
国United States of America
郵便番号34677
電話番号18137492104
ウェブサイトhttps://www.cryo-cell.com/
企業コードCCEL
上場日Apr 04, 1994
最高経営責任者「CEO」Mr. Mark L. Portnoy
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
株主
更新時刻: Sat, May 17
更新時刻: Sat, May 17
株主統計
種類
株主統計
株主統計
比率
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
株主統計
株主統計
比率
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
種類
株主統計
比率
Individual Investor
40.39%
Investment Advisor
6.26%
Private Equity
5.09%
Hedge Fund
0.80%
Investment Advisor/Hedge Fund
0.64%
Other
46.83%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
38
4.28M
53.09%
-1.50K
2025Q1
39
4.88M
60.37%
-1.40K
2024Q4
36
4.88M
60.35%
-45.33K
2024Q3
31
4.73M
58.53%
-190.45K
2024Q2
32
4.72M
57.24%
-175.49K
2024Q1
34
4.70M
56.72%
-231.88K
2023Q4
36
4.69M
56.61%
-257.13K
2023Q3
34
4.69M
56.58%
-265.51K
2023Q2
34
4.80M
57.00%
-223.23K
2023Q1
36
5.70M
67.38%
-813.20K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Portnoy (David I)
1.57M
19.44%
--
--
Feb 28, 2025
Portnoy (Mark)
935.77K
11.58%
--
--
Feb 28, 2025
Fleishman (Adam)
509.00K
6.3%
--
--
Feb 28, 2025
Hamilton Lane Advisors, LLC
409.73K
5.07%
--
--
Jun 30, 2025
SFI Advisors LLC
165.30K
2.05%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
118.23K
1.46%
+1.28K
+1.09%
Mar 31, 2025
The MassMutual Trust Company, FSB
111.03K
1.37%
--
--
Mar 31, 2025
Mikulinsky (Oleg)
104.35K
1.29%
--
--
Feb 28, 2025
Berger (Harold D)
50.40K
0.62%
--
--
Feb 28, 2025
Topline Capital Management, LLC
47.79K
0.59%
--
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
比率0.01%
配当金
過去5年間の配当金総支払額は
9.69M
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Jan 29, 2025
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Feb 28, 2025
Feb 14, 2025
Oct 31, 2024
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
